Skip to main content
. 2016 Feb 20;7(14):17805–17814. doi: 10.18632/oncotarget.7525

Figure 6. MiR-222 treatment inhibits ARID1A protein expression.

Figure 6

(A) Total proteins from As-T and B2B cells were used to determine protein levels of ARID1A using Western blotting. (B) As-T cells and (C) BEAS-2B cells were transfected using miR-NC or miR-222 mimic, and the expression levels of ARID1A protein in the cells were detected using Western blotting 48 h after the transfection. (D) As-T cells and (E) A549 cells were transfected using anti-miR-NC or anti-miR-222 inhibitor, and analyzed as above.